CureVac is suing fellow German pharmaceutical company BioNTech, claiming that the Covid-19 vaccine maker infringed vital patents relating to messenger RNA technology.
The Tübingen-based group has filed a lawsuit in a German court seeking “fair compensation” for alleged infringements of its intellectual property rights in the development of the Covid shot made by BioNTech and US drugmaker Pfizer.
But it said it was not planning any action that would affect the production, sale or distribution of the vaccine.
您已閱讀35%（513字），剩余65%（968字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。